Johnson & Johnson and Varian Medical Systems are in line for exits after cancer therapy developer Fusion filed for a $100m initial public offering.

The cancer diagnostics technology developer, formed five years ago when Qiagen acquired part of Enzymatics, has filed to float on the Nasdaq Global Market.

Varian Medical Systems and Johnson & Johnson Innovation – JJDC returned for the series C-1 round having backed the histotripsy technology developer's series C last year.

The hearing loss treatment developer has filed to raise up to $100m, three months after a $105m round featuring Novartis, Partners HealthCare and Pivotal BioVenture Partners.

Sunshine Insurance participated in a $70.7m round for the contract biopharmaceutical services provider that follows $59m last year.

The advanced body scanner developer has boosted the SK Telecom, Foxconn and Fujifilm-backed round to $51m and is now valued at about $600m.

DocsApp, whose investors include DeNA and Techmatrix, has joined forces with MediBuddy in deal buoyed by a $20m round backed by Mitsui Sumitomo.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The classified listings group is putting up about $46m for Info Edge Venture Fund and expects to mobilise external backers to hit a $100m target.

Medical consultation platform developer Ubie has received $18.4m from medicine distributor Suzuken that will be used to enhance its apps, increase headcount and expand internationally.